Speculation that there is a buyout coming for ACAD today, has led the stock higher by 17%. But I believe the advance in the stock today, is due to the planned filing of their NDA (new drug application) for Nuplazid, for Parkinson's Disease Psychosis or (PDP), and an analyst price reiteration at noon. Either way the stock is getting a nice upside lift today, even as the overall market is selling off. Below is a daily chart of ACAD.
.png)
No comments:
Post a Comment